کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
2500995 1557312 2016 8 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Apomorphine and its esters: Differences in Caco-2 cell permeability and chylomicron affinity
موضوعات مرتبط
علوم پزشکی و سلامت داروسازی، سم شناسی و علوم دارویی علوم دارویی
پیش نمایش صفحه اول مقاله
Apomorphine and its esters: Differences in Caco-2 cell permeability and chylomicron affinity
چکیده انگلیسی

Oral delivery of apomorphine via prodrug principle may be a potential treatment for Parkinson’s disease. The purpose of this study was to investigate the transport and stability of apomorphine and its esters across Caco-2 cell monolayer and their affinity towards chylomicrons. Apomorphine, monolauroyl apomorphine (MLA) and dilauroyl apomorphine (DLA) were subjected to apical to basolateral (A-B) and basolateral to apical (B-A) transport across Caco-2 cell monolayer. The stability of these compounds was also assessed by incubation at intestinal pH and physiological pH with and without Caco-2 cells. Molecular dynamics (MD) simulations were performed to understand the stability of the esters on a molecular level. The affinity of the compounds towards plasma derived chylomicrons was assessed. The A-B transport of intact DLA was about 150 times lower than the transport of apomorphine. In contrast, MLA was highly unstable in the aqueous media leading to apomorphine appearance basolaterally. MD simulations possibly explained the differences in hydrolysis susceptibilities of DLA and MLA. The affinity of apomorphine diesters towards plasma derived chylomicrons provided an understanding of their potential lymphatic transport. The intact DLA transport is not favorable; therefore, the conversion of DLA to MLA is an important step for intestinal apomorphine absorption.

Schematic representation of transport of apomorphine and its esters across Caco-2 cell monolayer.Figure optionsDownload high-quality image (135 K)Download as PowerPoint slide

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: International Journal of Pharmaceutics - Volume 509, Issues 1–2, 25 July 2016, Pages 499–506
نویسندگان
, , , , , , , , ,